Seeking Alpha

Mayo clinic closes study of Geron's Imetelstat to new patients

  • The Mayo Clinic has closed the trial of Geron's (GERN) Imetelstat treatment to new patients after 14 months, although those who are already in the program will continue to receive therapy.
  • The study is evaluating Imetelstat in patients with myelofibrosis and other myeloid malignancies.
  • Geron believes that 79 patients were enrolled in the trial but that 20 have dropped out.
  • Based on preliminary data from the study, Geron intends to start another Phase II trial in H1.
  • Shares are -12.1%; Adam Feuerstein asks on Twitter whether people are "bothered by the 20 patients who dropped out of study?" (8-K)
Comments (8)
  • billeebong
    , contributor
    Comments (169) | Send Message
     
    ...really. I'd like to see how people panic when a commercial flight closes the door for takeoff. That's all this is but you'd never know it by the market response...
    27 Jan, 08:56 AM Reply Like
  • Sidrico
    , contributor
    Comments (66) | Send Message
     
    Does AF like anything besides hearing himself talk?
    27 Jan, 09:12 AM Reply Like
  • wecap
    , contributor
    Comments (38) | Send Message
     
    Adam sucks
    27 Jan, 09:18 AM Reply Like
  • pat walsh
    , contributor
    Comments (210) | Send Message
     
    AF is just a hack.
    27 Jan, 10:51 AM Reply Like
  • Matija Snuderl
    , contributor
    Comments (176) | Send Message
     
    I love how all what it takes is a one little tweet from Adam F. and people panic. He must be laughing. I bet he enjoys the power he has over the weak hearts. If imetelstat works on "only" ~75% of patients with myelofibrosis (2o dropped out of ~80), this wil be one of the most remarkable breakthroughs in this disease. So my answer to Adam F. is, no, I am not bothered.
    27 Jan, 10:58 AM Reply Like
  • jeffreyr
    , contributor
    Comment (1) | Send Message
     
    I'm not bothered at all , emotional traders are silly. Just consider this a buying opportunity for the big players!!!
    27 Jan, 11:47 AM Reply Like
  • User 19606611
    , contributor
    Comment (1) | Send Message
     
    5 out of 22 (23%) dropping out of the first cohort is roughly the same as 15 dropping out of the next 57 (26%). Seems consistent to me, thus confirming the initial excitement not negating it in my estimation. M.Gold
    27 Jan, 12:18 PM Reply Like
  • chebyshev
    , contributor
    Comments (6) | Send Message
     
    I have bought 10k today, let Adam tweet more of that.
    27 Jan, 07:38 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|